Waystar touts expansion across client base ai capabilities q3 2026

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 04 Nov, 19:37 UTC

Waystar again outperformed analysts’ estimates in the third quarter as the company builds out new AI capabilities and drives growth by adding new customers and selling more of its platform to existing clients.